RxDoctor Payments Data

Sudeshna Banerjee, MD

Interventional Cardiology · Springfield, ORNPI 1093926081

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (30.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 28.3% of the total. Among interventional cardiology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,337in general payments, 2019–2025

Across 327 payments — averaging $202.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$19K
  • Abbott$18K
  • Medtronic$12K
  • Shockwave Medical, Inc$9K
  • Penumbra, Inc.$3K
  • Edwards Lifesciences$3K
  • plus $3K from 9 others
$279,504in research payments, 2019–2025

Across 58 payments — averaging $4819.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$280K

What the payments were for

  • Consulting fees$19,87330%
  • Speaking & faculty fees$19,48829%
  • Travel & lodging$10,99917%
  • Food & beverage$15,97724%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,337 in reported general payments places this provider in the 90th percentile of 68 interventional cardiology providers in Oregon.

See all interventional cardiology providers in Oregon

Medicare billing

Part B allowed, 2024
$203,971
Medicare patients
1,672
Services billed
2,981

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban57$82,762
Repatha SureclickEvolocumab14$13,649
ClopidogrelClopidogrel Bisulfate256$2,378
Atorvastatin Calcium97$1,693
Metoprolol Succinate78$1,423
Ezetimibe25$798
Carvedilol64$783
Amlodipine Besylate59$641
Isosorbide Mononitrate ErIsosorbide Mononitrate35$626
Potassium Chloride16$330
Lisinopril27$316
Furosemide40$301
Nitroglycerin20$254
Losartan Potassium24$242
Spironolactone25$205

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Springfield

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →